GeoVax (GOVX) Reports Both Favorable Safety and “It’s Working” News for its Cancer...
Official Headline is "GeoVax Announces JCO Oncology Advances Publication Highlighting Favorable Safety and Evidence of Disease Stability of Gedeptin(R) in Recurrent Head & Neck...
Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture
BioPharm
David Dodd, GeoVax Labs (NASDAQ: GOVX), opines on why vaccine platform diversity is critical in the United States.
Editor's Note: The views an opinions expressed...
Happy News! GSK (GSK) Just Paid $367 Million, for Synvidia’s Pre-Clinical Trial Cancer Treatment.
One of the Fun Features of Biotech Investing, is Getting Paid on a Treatment That Hasn't Even Entered Clinical Trials.
A lot of investors...
We’re Up 118% on Allarity (ALLR) Today.
Since adding Allarity (ALLR) to the Watch List at $0.70, we are up 194%, and that ain't bad - for exactly 4 months and...
GeoVax (GOVX) Comments on HHS mRNA Vaccine Rollback: Urges Full Embrace of MVA-Based Multi-Antigen...
https://youtu.be/4LffUyg6yE8?si=G8_kZMce8yHGCxKp
GEO-CM04S1 Offers Solution to Overcome HHS-Cited mRNA Deficiencies - Potentially Offering Broader, More Durable Protection
ATLANTA, GA - August 7, 2025 (NEWMEDIAWIRE) - GeoVax Labs,...
Compass Pathways (CMPS) $4.44, Gains 85% Since Adding to Watch List.
Down from $56.95 - But Up from $2.36. Woo hoo!
Compass Pathways (CMPS) Gets a Beat Down. Adding to 2025 Watch List, $2.36
We are probably...
Our 4th Billion Dollar Takeover! Bavarian Nordic (BVRNY) $12.25, gains 149% After Adding to...
Two Doubles, From the Same Stock!
Been quite sometime since we had Watch List company taken out, at over $1 Billion but here we go...
Vystar (VYST)$0.16. While Shares not yet Actively Trading, Gains 54% From Adding to Watch...
World's Best Air Purifier, FDA Cleared (Medical), Gets a Boost.
(Just to be clear, this is not your everyday $200 Walmart air cleaner, using HEPA...
GeoVax (GOVX) Accelerates Development of GEO-MVA Vaccine Amid Expanding Global Mpox Crisis and Reaffirmed...
EMA Scientific Guidance, Global Surge in Clade I Mpox, and Aid Shortfalls Drive Urgent Need for Scalable, Equitable Vaccine Solutions
LIVE QUOTE
ATLANTA, GA - July...
Cardiol Therapeutics (CRDL) May 2025 Presentation.
Click here to open.
RELATED: Cardiol’s (CRDL) Game-Changing Solution for Heart Inflammation? | David Elsley CEO – Video Interview















